365 related articles for article (PubMed ID: 24798149)
21. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
Surcel CI; Sooriakumaran P; Briganti A; De Visschere PJ; Fütterer JJ; Ghadjar P; Isbarn H; Ost P; Ploussard G; van den Bergh RC; van Oort IM; Yossepowitch O; Sedelaar JP; Giannarini G; ;
BJU Int; 2015 Apr; 115(4):571-9. PubMed ID: 24802335
[TBL] [Abstract][Full Text] [Related]
22. Practice patterns in screening and management of prostate cancer in elderly men.
Konety BR; Sharp VJ; Verma M; Williams RD;
Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
[TBL] [Abstract][Full Text] [Related]
23. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
24. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
van Rij S; Dowell T; Nacey J
N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
[TBL] [Abstract][Full Text] [Related]
25. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
[TBL] [Abstract][Full Text] [Related]
26. Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center.
Lin YK; Gettle L; Raman JD
Urology; 2011 Aug; 78(2):244-8. PubMed ID: 21664655
[TBL] [Abstract][Full Text] [Related]
27. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
[TBL] [Abstract][Full Text] [Related]
28. PSA screening: determinants of primary-care physician practice patterns.
Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer screening practices and beliefs.
Voss JD; Schectman JM
J Gen Intern Med; 2001 Dec; 16(12):831-7. PubMed ID: 11903762
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
Kell JS
Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
32. The age of the urologist affects the postoperative care of prostate carcinoma patients.
Tsai DY; Virgo KS; Colberg JW; Ornstein DK; Johnson ET; Chan D; Johnson FE
Cancer; 1999 Oct; 86(7):1314-21. PubMed ID: 10506719
[TBL] [Abstract][Full Text] [Related]
33. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer screening and informed decision-making: provider and patient perspectives.
Bowen DJ; Hannon PA; Harris JR; Martin DP
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):155-61. PubMed ID: 21243007
[TBL] [Abstract][Full Text] [Related]
35. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
[TBL] [Abstract][Full Text] [Related]
36. [Observational survey of the French Urological Association evaluating intermittent hormonal modalities treatment in prostate cancer in France].
Salomon L; Ploussard G; Coloby P; Kouri G; Lebret T; Méjean A; Prunet D; Soulié M
Prog Urol; 2014 May; 24(6):367-73. PubMed ID: 24821560
[TBL] [Abstract][Full Text] [Related]
37. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
38. In the Era of Shared Decision Making, How Would An Iranian Urologist Screen Himself For Prostate Cancer?
Ali Asgari M; Soleimani M; Dadkhah F; Lashay A; Amini E; Baikpour M; Amraei R
Urol J; 2015 Dec; 12(6):2404-9. PubMed ID: 26706736
[TBL] [Abstract][Full Text] [Related]
39. Initiation of salvage therapy for prostate cancer.
Johnstone PA; Booth R; Riffenburgh RH; Amling CL; Kane CJ; Moul JW
Prostate Cancer Prostatic Dis; 2002; 5(2):136-43. PubMed ID: 12497004
[TBL] [Abstract][Full Text] [Related]
40. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]